Physical activity promotion for multimorbid patients in primary care settings: a protocol for a systematic review evaluating health benefits and harms
Tóm tắt
To date multimorbidity has not received much attention in health policies, even though multiple chronic diseases put high demands on the health care system in industrial nations. Enormous costs of care and a physically, mentally, and socially reduced quality of life are common consequences of multimorbidity. Physical activity (PA) has a positive preventive and therapeutic effect on common non-communicable diseases. The objective of this study will be to evaluate the health benefits and harms of PA interventions for sedentary adults with multimorbidity in primary care settings. This is the study protocol for a systematic review. We will search PubMed, MEDLINE (Ovid), Web of Science, CINHAL, and the Cochrane Library (from inception onwards). In addition, clinical trial registers and reference lists of included studies will be searched. We will include randomized controlled trials, quasi-experimental, and non-randomized trials examining the health benefits and harms of PA interventions with or without additional lifestyle interventions for sedentary adult patients with multimorbidity (e.g., two or more chronic non-communicable diseases) in primary care. Eligible control groups will be standard care, placebo, or medications. Two reviewers will independently screen all citations, abstracts data, and full-text articles. The primary outcomes will be health-related quality of life and mortality. Secondary outcomes will include cardiovascular fitness, muscular strength and disease-specific outcomes (e.g., depression score), biomarkers as well as control of metabolic risk factors (e.g., blood pressure, HBA1c, body weight) and any adverse event. The methodological quality of the studies will be appraised using appropriate tools. If feasible, we will conduct random effects meta-analysis. Additional analyses will be conducted to explore the potential sources of heterogeneity (e.g., study design, geographical location, or type of intervention). Strength of the body of evidence will be assessed according to the Grading of Recommendations Assessment (GRADE). This review will evaluate the evidence on health benefits and harms of PA interventions for sedentary adults with multimorbidity in primary care settings. We anticipate our findings to be of interest to patients, their families, caregivers, and healthcare professionals in selecting and conducting optimal health promotion programs. Possible implications for further research will be discussed. Open Science Framework (registration identifier: osf.io/ka8yu)
Tài liệu tham khảo
Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: systematic literature review and meta-analysis. Ageing Res Rev. 2019.
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430–9.
Rijken M, Hujala A, van Ginneken E, Melchiorre MG, Groenewegen P, Schellevis F. Managing multimorbidity: Profiles of integrated care approaches targeting people with multiple chronic conditions in Europe. Health Polica. 2017;9.
Altern im Wandel, Motel-Klingebiel A, Wurm S, Tesch-Römer C, editors. Stuttgart: W. Kohlhammer GmbH + Co.KG; 2010. 307 p.
Struckmann V, Melchiorre MG, Hujala A, Rijken M, Quentin W, van Ginneken E. Caring for people with multiple chronic conditions in Europe. Eurohealth incorporating Euro Observer. 2014;20(3).
Rijken M, Struckmann V, Dyakova M, Melchiorre MG, Rissanen S, Van Ginneken E. ICARE4EU: Improving care for people with multiple chronic conditions in Europe. Eurohealth incorporating Euro Observer. 2013;19(3):29–31.
Fortin M, Soubhi H, Hudon C, Bayliss EA, van den Akker M. Multimorbidity's many challenges. British Medical Journal. 2007;334.
de Souto Barreto P. Exercise for Multimorbid Patients in Primary Care: One Prescription for All? Sports medicine (Auckland, NZ). 2017;47(11):2143-2153.
Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation. Nature reviews Rheumatology. 2015;11(2):86–97.
Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006;16(Suppl 1):3–63.
Skou ST, Pedersen BK, Abbott JH, Patterson B, Barton C. Physical activity and exercise therapy benefits more than just symptoms and impairments in people with hip and knee osteoarthritis. J Orthop Sports Phys Ther. 2018;48(6).
Fiuza-Luces C, Garatachea N, Berger NA, Lucia A. Exercise is the real polypill. Physiology (Bethesda, Md). 2013;28(5):330–58.
Pareja-Galeano H, Garatachea N, Lucia A. Exercise as a Polypill for Chronic Diseases. Prog Mol Biol Transl Sci. 2015;135:497–526.
Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl 3):1–72.
Smith SM, Wallace E, O'Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2017;3:Cd006560.
Courneya KS. Efficacy, effectiveness, and behavior change trials in exercise research. Int J Behav Nutr Phys Act. 2010;7:81.
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–84.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediators of inflammation. 2008;2008:109502.
Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health and Quality of Life Outcomes. 2013;11(1):110.
Sullivan M, Karlsson J, Ware JE. The Swedish SF-36 Health Survey—I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41(10):1349–58.
Spitzer RL, Kroenke K, Williams JBW. Group atPHQPCS. Validation and Utility of a Self-report Version of PRIME-MD. The PHQ Primary Care Study. Jama. 1999;282(18):1737–44.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.
Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) – validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003;1(1):17.
Reviewer's Manual. Australia: Joanna Briggs institute 2014 [Available from: https://joannabriggs.org/critical_appraisal_tools.
Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness 2017 [Available from: https://reviewersmanual.joannabriggs.org/.
Cumming G, Calin-Jageman R. Introduction to the New Statistics. New York: Routledge; 2017. 564 p.
Schwarzer G, Carpenter JR, Rücker G. Meta-Analysis with R. Gentleman R, Hornik K, Parmigiani G, editors. Cham, Heidelberg, New York, Dordrecht, London: Springer Interantional Publishing Switzerland; 2015.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed). 2008;336(7650):924–6.
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.